Technology News and Research

RSS

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.

12 Oct 2009

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields.

12 Oct 2009

OSI Systems receives $1.3 million order from Thomas Memorial Hospital for its patient monitoring products

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.

12 Oct 2009

CED to host popular STREAK program

CED, formerly the Council for Entrepreneurial Development (www.cednc.org), a private, nonprofit organization that promotes entrepreneurial efforts in the Triangle region of North Carolina, has announced that it will host the next installment of its popular STREAK program, to be held Thursday, Oct. 8 from 3 p.m. to 5 p.m.

12 Oct 2009

Santarus and Norgine enter into a licensing agreement for ZEGERID products

Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.

12 Oct 2009

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

GE Healthcare (NYSE:GE) wishes to issue the following update and correction to its release NewsItemID 20090923005515 (GE-HEALTHCARE) "GE Healthcare Launches Global Initiative to Celebrate the 10th Anniversary of Digital Mammography" issued September 23, 2009/

12 Oct 2009

Navinet to outline ways in which healthcare providers can maximize reimbursement in a post-CDH world

NaviNet, America’s largest real-time healthcare communications network, announces that Timothy Mills, senior vice president, provider operations, will speak about how healthcare providers can maximize reimbursement in a post-CDH world, at the MGMA 2009 Annual Conference, held in Denver, Colorado from October 11-14, 2009.

12 Oct 2009

InTouch Health to feature at FiReGlobal's conference

FiReGlobal : West Coast is proud to announce that InTouch Health has been selected as a FiReStar company to be featured at the FiReGlobal : West Coast conference.

12 Oct 2009

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

In a continuing series called “Exciting Biologies” Cell Press, Massachusetts General Hospital and La Fondation Ipsen collaborate to offer annual meetings designed to highlight emerging intersections in biomedical research and promote interactions between scientists from converging disciplines. This third meeting, held in Buenos Aires between the 8th and 10th of October, focused on “Biology in Balance”.

12 Oct 2009

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.

12 Oct 2009

UK Bioscientists create GM knowledge pipeline to help fight future food insecurity in African nations

UK Bioscientists are transferring GM knowledge and technology from the developed to the developing world to help fight future food insecurity in Sub-Saharan Africa.

12 Oct 2009

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Nektar Therapeutics presented topline data today from its Phase 2 clinical trial of oral NKTR-118 at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting in Phoenix, Arizona.

12 Oct 2009

Heptares Therapeutics to apply its StaR technology to generate novel drug leads against GPCR target

Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, announced today that it has entered into an option agreement with the Novartis Option Fund under which Heptares will apply its proprietary StaR(TM) technology to generate novel drug leads against a nominated, unspecified GPCR target of interest to Novartis.

12 Oct 2009

Federal stimulus funds for comparative-effectiveness research in cancer

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

12 Oct 2009

New device minimizes brain damage by speeding the delivery of post-stroke countermeasures

A new device from NeuroInterventions, Inc., is designed to minimize brain damage by dramatically speeding the delivery of post-stroke countermeasures.

12 Oct 2009

VitalWear partners with XBACK Bracing Services to deliver innovative products

VitalWear, Inc. (www.vitalwear.com), a leader in thermal compression medical devices announced that they have formed a partnership with XBACK Bracing Services (www.xbackbrace.com) revolutionizing the bracing and thermal therapy markets. (www.thexbackvwsolution.com)

12 Oct 2009

MDMA opposes medical device tax as part of the health care reform bills

Yesterday, the Medical Device Manufacturers Association Board of Directors met and unanimously voted to oppose any device tax as part of the health care reform bills moving through Congress.

12 Oct 2009

CCHIT certifies Eclipsys’ PeakPractice EMR/PM solution

Eclipsys Corporation®, The Outcomes Company®, today announced that the Certification Commission for Health Information Technology (CCHIT®) has listed its PeakPractice™ solution (version 1093) a CCHIT Certified® 08 Ambulatory electronic health record (EHR), and meets the Certification Commission’s EHR criteria for office-based use.

12 Oct 2009

DNA Guide's personal genome management software demonstrated at the Health 2.0 conference

DNA Guide presented a live demo of its unique personal genome management software on the main stage of the Health 2.0 conference in San Francisco on October 7th. DNA Guide’s software is based on an issued US patent (US Patent: 7089498) whereby the values in a persons DNA are used for security and then Geographic Information Systems technology is utilized to place massive genetic datasets in a visual format - effectively opening up DNA navigation to a whole new audience.

12 Oct 2009

Dilon Diagnostics and Philips sign distribution agreement

Dilon Diagnostics, the leader in molecular breast imaging (MBI) also known as Breast-Specific Gamma Imaging (BSGI) and Philips (NYSE: PHG, AEX: PHI), today announce that they have entered into a distribution agreement. Philips Healthcare will sell and support the Dilon 6800 gamma camera in key European and Middle Eastern markets. The compact camera technology and related products and services are used for the detection of breast cancer as an adjunct to mammography and serve to complement Philips innovative women's health solutions.

12 Oct 2009

Technology News and Research

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

Orion Genomics enters collaboration and license agreement with Novartis Pharma

OSI Systems receives $1.3 million order from Thomas Memorial Hospital for its patient monitoring products

CED to host popular STREAK program

Santarus and Norgine enter into a licensing agreement for ZEGERID products

GE Healthcare launches global initiative to celebrate 10th anniversary of digital mammography

Navinet to outline ways in which healthcare providers can maximize reimbursement in a post-CDH world

InTouch Health to feature at FiReGlobal's conference

The third “Exciting Biologies” meeting focuses on “Biology In Balance”

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

UK Bioscientists create GM knowledge pipeline to help fight future food insecurity in African nations

Nektar Therapeutics presents the results from Phase 2 clinical trial of oral NKTR-118

Heptares Therapeutics to apply its StaR technology to generate novel drug leads against GPCR target

Federal stimulus funds for comparative-effectiveness research in cancer

New device minimizes brain damage by speeding the delivery of post-stroke countermeasures

VitalWear partners with XBACK Bracing Services to deliver innovative products

MDMA opposes medical device tax as part of the health care reform bills

CCHIT certifies Eclipsys’ PeakPractice EMR/PM solution

DNA Guide's personal genome management software demonstrated at the Health 2.0 conference

Dilon Diagnostics and Philips sign distribution agreement

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News